Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas D James

Showing results (51-60 of 198) with videos related to

Pageof 20
Sort By:
BJU International|May 12, 2019
Health-related quality of life around the time of diagnosis in patients with bladder cancerEvan Yi-Wen Yu, Duncan Nekeman, Lucinda J Billingham, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the <i>TERT</i> 228 G>A/T MutationIlaria J Russo, Yongwon Ju, Naheema S Gordon, et al.
European Urology|May 11, 2021
Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?Richard T Bryan, James W F Catto, Kieran P Jefferson, et al.
Frontiers in Oncology|July 17, 2020
Back-Splicing Transcript Isoforms (Circular RNAs) Affect Biologically Relevant Pathways and Offer an Additional Layer of Information to Stratify NMIBC PatientsAnshita Goel, Douglas G Ward, Naheema S Gordon, et al.
BJU International|July 31, 2022
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancerNicholas D James, Wenyu Liu, Sarah Pirrie, et al.
Urology|July 19, 2024
Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over TimeAlex Sankin, Priya Dave, Louise-Rae Cherrill, et al.
European Urology Oncology|August 15, 2019
Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015Mehran Afshar, Hiten R H Patel, Maria De-Santis, et al.
Frontiers in Oncology|March 15, 2021
PD-L2 Is Constitutively Expressed in Normal and Malignant UrotheliumAlexander C Dowell, Haydn Munford, Anshita Goel, et al.
World Journal of Urology|March 24, 2019
Patients choose certainty over burden in bladder cancer surveillanceFrits H M van Osch, Duncan Nekeman, Neil K Aaronson, et al.
Brain : a Journal of Neurology|June 19, 2018
Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injuryEmily R Burnside, Fred De Winter, Athanasios Didangelos, et al.
Pageof 20

Showing results (51-60 of 198) with videos related to

Sort By:
Pageof 20
BJU International|May 12, 2019
Health-related quality of life around the time of diagnosis in patients with bladder cancerEvan Yi-Wen Yu, Duncan Nekeman, Lucinda J Billingham, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the <i>TERT</i> 228 G>A/T MutationIlaria J Russo, Yongwon Ju, Naheema S Gordon, et al.
European Urology|May 11, 2021
Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?Richard T Bryan, James W F Catto, Kieran P Jefferson, et al.
Frontiers in Oncology|July 17, 2020
Back-Splicing Transcript Isoforms (Circular RNAs) Affect Biologically Relevant Pathways and Offer an Additional Layer of Information to Stratify NMIBC PatientsAnshita Goel, Douglas G Ward, Naheema S Gordon, et al.
BJU International|July 31, 2022
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancerNicholas D James, Wenyu Liu, Sarah Pirrie, et al.
Urology|July 19, 2024
Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over TimeAlex Sankin, Priya Dave, Louise-Rae Cherrill, et al.
European Urology Oncology|August 15, 2019
Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015Mehran Afshar, Hiten R H Patel, Maria De-Santis, et al.
Frontiers in Oncology|March 15, 2021
PD-L2 Is Constitutively Expressed in Normal and Malignant UrotheliumAlexander C Dowell, Haydn Munford, Anshita Goel, et al.
World Journal of Urology|March 24, 2019
Patients choose certainty over burden in bladder cancer surveillanceFrits H M van Osch, Duncan Nekeman, Neil K Aaronson, et al.
Brain : a Journal of Neurology|June 19, 2018
Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injuryEmily R Burnside, Fred De Winter, Athanasios Didangelos, et al.
Pageof 20